Hypertension in the elderly;L'hypertension artérielle du sujet âgé

Bulletin de l'Academie Nationale de Medecine

Volumn 190, Issue 4-5, 2006, Pages 793-805

  Plouin, Pierre François ^a   Rossignol, Patrick ^a   Bobrie, Guillaume ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Blood pressure; Hypertension therapeutics

Indexed keywords

EID: 33751062782     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33264-9     Document Type: Article

References (47)

1. AMERY A., BIRKENHAGER W., BRIXKO P. et al. - Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet, 1985, 1, 1349-1354.
2. SHEP COOPERATIVE RESEARCH GROUP. - Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Med. Assoc., 1991, 265, 3255-3264.
3. MRC WORKING PARTY. - Medical Research Council trial of treatment of hypertension in older adults : principal results. Br. Med J., 1992, 304, 405-412.
4. WING L.M., REID C.M., RYAN P. et al. - A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N. Engl. J. Med., 2003, 348, 583-592.
5. DAHLOF B., LINDHOLM L.H., HANSSON L. et al. - Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet, 1991, 338, 1281-1285.
6. LITHELL H., HANSSON L., SKOOG I. et al. - The Study on Cognition and Prognosis in the Elderly (SCOPE) : principal results of a randomized double-blind intervention trial. J. Hypertens., 2003, 21, 875-886.
7. CHAUDHRY S.I., KRUMHOLZ H.M., FOODY J.M. - Systolic hypertension in older persons. J. Am. Med. Assoc., 2004, 292, 1074-1080.
8. BLACKER J., SAFAR M.E. - Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat. Clin. Pract. Cardiovasc. Med., 2005, 2, 450-455.
9. LEWINGTON S., CLARKE R., QIZILBASH N. et al. - Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 2002, 360, 1903-1913.
10. KEARNEY P.M., WHELTON M., REYNOLDS K. et al. - Global burden of hypertension : analysis of worldwide data. Lancet, 2005, 365, 217-223.
11. WOLF-MAIER K., COOPER R.S., BANEGAS J.R. et al. - Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. J. Am. Med. Assoc., 2003, 289, 2363-2369.
12. FRANKLIN S.S., JACOBS M.J., WONG N.D. et al. - Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives : analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension, 2001, 37, 869-874.
13. FRANKLIN S.S., PIO J.R., WONG N.D. et al. - Predictors of new-onset diastolic and systolic hypertension : the Framingham Heart Study. Circulation, 2005, 111, 1121-1127.
14. STAESSEN J.A., GASOWSKI J., WANG J.G. et al. - Risks of untreated and treated isolated systolic hypertension in the elderly : meta-analysis of outcome trials. Lancet, 2000, 355, 865-872.
15. BENETOS A., THOMAS F., BEAN K. et al. - Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch. Intern. Med., 2002, 162, 577-581.
16. SKOOG I., LERNFELT B., LANDAHL S. et al. - 15-year longitudinal study of blood pressure and dementia. Lancet, 1996, 347, 1141-1145.
17. GUEYFFIER F., BULPITT C., BOISSEL J.P. et al. - Antihypertensive drugs in very old people : a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet, 1999, 353, 793-796.
18. PROGRESS Collaborative Group. - Effects of Wood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med, 2003, 163, 1069-1075.
19. VEERMAN D.P., IMHOLZ B.P.M., WIELING W., KAREMAKER J.M., VAN MONTFRANS G.A. - Effects of aging on blood pressure variability in resting conditions. Hypertension, 1994, 24, 120-130.
20. BOBRIE G., CHATELLIER G., GENES N. et al. - Cardiovascular prognosis of " masked hypertension " detected by blood pressure self-measurement in elderly treated hypertensive patients. J. Am. Med. Assoc., 2004, 291, 1342-1349.
21. World Health Organization, International Society of Hypertension writing group. - 2003 World Health Organization/International Society of Hypertension statement on management of hypertension. J. Hypertens., 2003, 21, 1983-1992.
22. LEVEY A.S., BOSCH J.P., LEWIS J.B. et al. - A more accurate method to estimate glomerular nitration rate from serum creatinine : a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med., 1999, 130, 461-470.
23. CHOLESTEROL TREATMENT TRIALISTS' COLLABORATORS. Efficacy and safety of cholesterol-lowering treatment : prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005, 366, 1267-1278.
24. PLOUIN P.F., LA BATIDE ALANORE A., FIQUET-KEMPF B. et al. - Hypertensions secondaires à des causes curables chez l'adulte. Presse Med., 2002, 31, 371-378.
25. STREETEN D.H.P., ANDERSON G.H., WAGNER S. - Effect of age on response of secondary hypertension to specific treatment. Am. J. Hypertens., 1990, 3, 360-5.
26. PLOUIN P.F., CHATELLIER G., FOFOL I., CORVOL P. - Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension, 1997, 29, 1133-1139,
27. PLOUIN P.F., JEUNEMAITRE X. - Would wider screening for primary aldosteronism give any health benefits ? Eur. J. Endocrinol, 2004, 151, 305-308.
28. HANSEN K.J., EDWARDS M.S., CRAVEN TE. et al. - Prevalence of renovascular disease in the elderly : a population-based study. J. Vasc. Surg., 2002, 36, 443-451.
29. JULIEN J., JEUNEMAITRE X., RAYNAUD A. et al. - Influence of age on the outcome of percutaneous angioplasty in atheromatous renovascular disease. J. Hypertens., 1989, 7(suppl 6), S188-S189.
30. PLOUIN P.F., ROSSIGNOL P., BOBRIE G. - Atherosclerotic renal artery stenosis : to treat conservatively, to dilate, to stent or to operate ? J. Am. Soc. Nephrol, 2001, 12, 2190-2196.
31. NICOLSON D.J., DICKINSON H.O., CAMPBELL F., MASON J.M. - Lifestyle interventions or drugs for patients with essential hypertension : a systematic review. J. Hypertens., 2004, 22, 2043-2048.
32. WHELTON P.K., APPEL L.J., ESPELAND M.A. et al. - Sodium reduction and weight loss in the treatment of hypertension in older persons : a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. J. Am. Med. Assoc., 1998, 279, 839-846.
33. LARSON E.B., WANG L., BOWEN J.D. et al. - Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med., 2006, 144, 73-81.
34. BULPITT C.J., BECKETT N.S., COOKE J. et al. - Results of the pilot study for the Hypertension in the Very Elderly Trial. J. Hypertens., 2003, 21, 2409-2417.
35. KOSTIS J.B., COBBE S., JOHNSTON C. et al. - Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. Am. J. Hypertens., 2002, 15, 193-198.
36. WANG J.G., STAESSEN J.A., FRANKLIN S.S., FAGARD R., GUEYFFIER F. - Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension, 2005, 45, 907-913.
37. LINDHOLM L.H., CARLBERG B., SAMUELSSON O. - Should beta blockers remain first choice in the treatment of primary hypertension ? A meta-analysis. Lancet, 2005, 366, 1545-1553.
38. Blood pressure lowering treatment trialists' collaboration. - Effects of different blood-pressure-lowering regimens on major cardiovascular events : results of prospectively-designed overviews of randomised trials. Lancet, 2003, 362, 1527-1535.
39. VERDECCHIA P., REBOLDI G., ANGELI F. et al. - Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension, 2005, 46, 386-392.
40. STAESSEN J.A., BIRKENHAGER W.H. - Evidence that new antihypertensives are superior to older drugs. Lancet, 2005, 366, 869-871.
41. ALLHAT OFFICIERS AND COORDINATORS. - The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic : The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J. Am. Med. Assoc., 2002, 288, 2981-2997.
42. PEPINE C.J., HANDBERG E.M., COOPER-DEHOFF R.M. et al. - A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST) : a randomized controlled trial. J. Am. Med Assoc., 2003, 290, 2805-2816.
43. DAHLOF B., SEVER P.S., POULTER N.R. et al. - Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a multicentre randomised controlled trial. Lancet, 2005, 366, 895-906.
44. LENFANT C. - Clinical research to clinical practice : lost in translation ? N. Engl. J. Med., 2003, 349, 868-874.
45. BRINDEL P., HANON O., DARTIGUES J.F. et al. - Prevalence, awareness, treatment, and control of hypertension in the elderly : the Three City study. J. Hypertens., 2006, 24, 51-58.
46. LLOYD-JONES D.M., EVANS J.C., LEVY D. - Hypertension in adults across the age spectrum : current outcomes and control in the community. J. Am. Med. Assoc., 2005, 294, 466-472.
47. BERLOWITZ D.R., ASH A.S., HICKEY E.C. et al. - Inadequate management of blood pressure in a hypertensive population. N. Engl. J. Med., 1998, 339, 1957-1963.